Please assess the completion status of the following clinical trial:

Trial Title: Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* • All patients undergoing elective laparoscopic or open colorectal resections who are eligible for IT~  * Age \>18 years~ * BMI \<40~ * Ability to understand and read English~Exclusion Criteria:~* • Not able or unwilling to sign consent.~  * Currently pregnant or lactating.~ * Patients with chronic pain, requiring daily opiate use at time of surgery.~ * Patients intolerant of opiates, NSAIDS, acetaminophen or local anesthetics.~ * Patients requiring emergent surgery.~ * Abdominoperineal resections~ * Any contraindications to neuraxial analgesia (coagulopathy, localized infection at the potential site of injection, pre-existing spinal canal pathology)~ * Patients with a diagnosis of inflammatory bowel disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TAP block (EXPAREL) (Type: ACTIVE_COMPARATOR): After induction of anesthesia, the patients will receive a single injection with 133 mg of EXPAREL in the transversus abdominis plane (TAP), on each side, suspended in 20 milliliters (mL) of injectable saline.
- Intrathecal opioid (IT) (Type: ACTIVE_COMPARATOR): single injection intrathecal hydromorphone analgesia given preoperatively

Based on this trial design, predict the completion outcome and termination type (if applicable).